Colon

In a study of more than 100,000 people, researchers found that people with a less healthy lifestyle (higher BMI, greater smoking, greater alcohol consumption, less physical activity, poorer diet quality) had a greater reduction in risk of colorectal cancer associated with aspirin use, compared to participants with a healthier lifestyle. Participants with a healthier lifestyle

A noninvasive colorectal cancer screening test that can be done at home could reduce the risk of colorectal cancer death by 33%, according to a new study. A noninvasive colorectal cancer screening test that can be done at home could reduce the risk of colorectal cancer death by 33%, according to a new study published

Findings from a small, proof-of-concept clinical trial have suggested that fecal microbiota transplants (FMTs) can boost the effectiveness of immunotherapy in a range of gastrointestinal cancers. In the study, six of 13 patients who had previously shown resistance to immune checkpoint inhibitors benefited from receiving FMTs from donors who had previously responded to treatment. The

Journal of Veterinary Research outlines how the kinase, called TLK1, plays a key role in regulating cellular processes. This groundbreaking discovery could lead to new targeted therapies for colorectal cancer, offering hope for patients with this difficult-to-treat disease. The research not only sheds light on the underlying mechanisms of cancer, but also highlights the potential for personalized medicine in the future. With its potential to revolutionize cancer treatment, this study marks a significant milestone in the field of veterinary medicine

Shrink or stabilize. This promising development could provide a new treatment option for patients with advanced colorectal cancer, offering hope for improved outcomes and quality of life. The potential for immunotherapy to target MSS mCRC specifically sets it apart as a groundbreaking advancement in the field of cancer treatment. With further research and development, this approach has the potential to revolutionize the way we approach and manage colorectal cancer

A groundbreaking AI-powered system for tracking disease markers in the gut. This innovation allows at-risk individuals to monitor their GI health at home without invasive tests. With the potential to revolutionize healthcare, this system offers a non-invasive and convenient solution for managing GI tract health

Intestinal condition that can cause severe discomfort and disrupt daily life. However, with the right management and treatment, individuals with UC can lead a full and healthy life. This post explores the pivotal features, advantages, and distinctive qualities of living with ulcerative colitis, providing valuable insights and support for those affected by this condition. From dietary tips to medication management, this post aims to empower and inform individuals with UC, as well as their loved ones, in navigating the challenges and triumphs of living with this chronic condition

Groundbreaking insights into the early stages of colorectal cancer development. By identifying the loss of intestinal stem cells as the starting point, this research offers potential for early detection and intervention. This discovery challenges existing understanding and opens up new possibilities for diagnosing and treating colorectal cancer. The findings from Weill Cornell Medicine could revolutionize our approach to this prevalent and deadly disease

Condition affecting around one per cent of the global population. Triggered by gluten consumption, it causes severe intestinal damage. To combat this, a gluten-free diet is crucial for celiac patients. On International Celiac Day, let's raise awareness about this condition and the importance of managing it through proper dietary measures

That target a specific signaling pathway involved in tumor growth. The research, published in the journal Cancer Cell, highlights the importance of understanding the underlying mechanisms of drug resistance and offers potential strategies to improve the effectiveness of Wnt inhibitors. This groundbreaking study opens up new possibilities for developing personalized treatment options for patients with these challenging, treatment-resistant cancers

CRC have also been associated with changes in the gut microbiome, suggesting a connection between KRAS mutations and microbial signatures. Understanding this link could pave the way for new targeted treatments and personalized interventions for CRC patients. This groundbreaking research sheds light on the potential impact of gut microbiota on cancer progression and offers hope for improved outcomes in the fight against colorectal cancer